Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
- Oktober -
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
- 2023 -
2024
Oktober 2023 - 50 products
IP
CI
CRYSALIS Leman
30 g
15.50
33.35
10 %
Ointment: 2 Active Agents
Leman SKL SA
B / SL / SG
FB
G
IP
CI
CRYSALIS Leman
60 g
27.25
46.25
10 %
Ointment: 2 Active Agents
Leman SKL SA
B / SL / SG
FB
G
IP
CI
CRYSALIS Leman
2 x 60 g
45.45
65.85
10 %
Ointment: 2 Active Agents
Leman SKL SA
B / SL / SG
FB
G
L
IP
CI
Abirateron Devatis 500 mg
56
808.02
899.90
10 %
Coated tablets: Abirateroni Acetas 500 mg
Devatis AG
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban Viatris 10 mg
10
6.72
16.60
10 %
Coated tablets: Rivaroxabanum 10 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban Viatris 10 mg
30
20.15
38.30
10 %
Coated tablets: Rivaroxabanum 10 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban Viatris 10 mg
98
69.13
91.65
10 %
Coated tablets: Rivaroxabanum 10 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
Rivaroxaban Viatris 15 mg
14
9.65
26.90
10 %
Coated tablets: Rivaroxabanum 15 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
Rivaroxaban Viatris 15 mg
28
18.75
36.80
10 %
Coated tablets: Rivaroxabanum 15 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
Rivaroxaban Viatris 15 mg
98
69.13
91.60
10 %
Coated tablets: Rivaroxabanum 15 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
Rivaroxaban Viatris 20 mg
14
9.71
27.00
10 %
Coated tablets: Rivaroxabanum 20 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
Rivaroxaban Viatris 20 mg
28
18.75
36.80
10 %
Coated tablets: Rivaroxabanum 20 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
Rivaroxaban Viatris 20 mg
98
69.13
91.60
10 %
Coated tablets: Rivaroxabanum 20 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
Talvey 3 mg/1.5 ml
356.16
403.75
10 %
Injection solution: Talquetamabum 3mg / 1.5ml
Janssen-Cilag AG
A / SL
FB
G
L
IP
Talvey 40 mg/1.0 ml
4748.80
5180.05
10 %
Injection solution: Talquetamabum 40 mg/ml
Janssen-Cilag AG
A / SL
FB
G
L
IP
CI
Vydura 75 mg
2
50.61
71.45
10 %
Soluble Powder: Rimegepantum 75 mg
Pfizer AG
B / SL
FB
G
L
IP
CI
Vydura 75 mg
8
202.53
236.70
10 %
Soluble Powder: Rimegepantum 75 mg
Pfizer AG
B / SL
FB
G
L
IP
CI
Vydura 75 mg
16
404.89
456.75
10 %
Soluble Powder: Rimegepantum 75 mg
Pfizer AG
B / SL
FB
G
L
IP
CI
Wynzora 50 μg/g + 0.5
mg/g
60 g
39.33
58.65
10 %
Cream: 2 Active Agents
Almirall AG
B / SL
FB
G
L
IP
CI
Wynzora 50 μg/g + 0.5
mg/g
120 g
69.22
90.25
10 %
Cream: 2 Active Agents
Almirall AG
B / SL
FB
G
L
IP
CI
Ilumetri, 100 mg/1 ml
2962.66
3238.50
10 %
Injektionslösung im Fertigpen: Tildrakizumabum 100 mg/ml
Almirall AG
B / SL
FB
G
IP
Budenofalk 4 mg
12
75.19
98.20
10 %
Zäpfchen: Budesonidum 4 mg
Dr. Falk Pharma AG
B / SL
FB
G
IP
Budenofalk 4 mg
60
323.32
368.05
10 %
Zäpfchen: Budesonidum 4 mg
Dr. Falk Pharma AG
B / SL
FB
G
IP
Oxaliplatin Zentiva 50
mg/10 ml
PR
PR
k.A.
Concentrate for infusion: Oxaliplatinum 50mg / 10ml
Helvepharm AG
A
FB
G
IP
Oxaliplatin Zentiva 100
mg/20 ml
PR
PR
k.A.
Concentrate for infusion: Oxaliplatinum 100mg / 20ml
Helvepharm AG
A
FB
G
IP
Oxaliplatin Zentiva 200
mg/40 ml
PR
PR
k.A.
Concentrate for infusion: Oxaliplatinum 200mg / 40ml
Helvepharm AG
A
FB
G
IP
Letybo 50 units
PR
PR
k.A.
Dry substance: Toxinum Botulinicum a (Stirpis Cbfc26) 50 U
Medius AG
A
FB
G
IP
Letybo 50 units
2
PR
PR
k.A.
Dry substance: Toxinum Botulinicum a (Stirpis Cbfc26) 50 U
Medius AG
A
FB
G
IP
Letybo 50 units
2
PR
PR
k.A.
Dry substance: Toxinum Botulinicum a (Stirpis Cbfc26) 50 U
Medius AG
A
FB
G
IP
Letybo 50 units
6
PR
PR
k.A.
Dry substance: Toxinum Botulinicum a (Stirpis Cbfc26) 50 U
Medius AG
A
FB
G
IP
Simulect 20 mg
PR
PR
k.A.
Dry substance: Basiliximabum 20 mg
Novartis Pharma
Schweiz AG
B
FB
G
Letrozol Accord 2,5 mg
30
PR
PR
k.A.
Coated tablets: Letrozolum 2.5 mg
Accord Healthcare AG
B
FB
G
Letrozol Accord 2,5 mg
100
PR
PR
k.A.
Coated tablets: Letrozolum 2.5 mg
Accord Healthcare AG
B
FB
G
Pazopanib Spirig HC 200 mg
30
PR
PR
k.A.
Coated tablets: Pazopanibum 200 mg
Spirig HealthCare AG
A
FB
G
Pazopanib Spirig HC 400 mg
60
PR
PR
k.A.
Coated tablets: Pazopanibum 400 mg
Spirig HealthCare AG
A
FB
G
IP
CI
Rivaroxaban Sandoz eco 10 mg
10
PR
PR
k.A.
Coated tablets: Rivaroxabanum 10 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Rivaroxaban Sandoz eco 10 mg
30
PR
PR
k.A.
Coated tablets: Rivaroxabanum 10 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Rivaroxaban Sandoz eco 10 mg
98
PR
PR
k.A.
Coated tablets: Rivaroxabanum 10 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Rivaroxaban Sandoz eco 10 mg
100
PR
PR
k.A.
Coated tablets: Rivaroxabanum 10 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Rivaroxaban Sandoz eco 15 mg
14
PR
PR
k.A.
Coated tablets: Rivaroxabanum 15 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Rivaroxaban Sandoz eco 15 mg
28
PR
PR
k.A.
Coated tablets: Rivaroxabanum 15 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Rivaroxaban Sandoz eco 15 mg
98
PR
PR
k.A.
Coated tablets: Rivaroxabanum 15 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Rivaroxaban Sandoz eco 15 mg
100
PR
PR
k.A.
Coated tablets: Rivaroxabanum 15 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Rivaroxaban Sandoz eco 20 mg
14
PR
PR
k.A.
Coated tablets: Rivaroxabanum 20 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Rivaroxaban Sandoz eco 20 mg
28
PR
PR
k.A.
Coated tablets: Rivaroxabanum 20 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Rivaroxaban Sandoz eco 20 mg
98
PR
PR
k.A.
Coated tablets: Rivaroxabanum 20 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Rivaroxaban Sandoz eco 20 mg
100
PR
PR
k.A.
Coated tablets: Rivaroxabanum 20 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
NeoCitran Grippe
Erkältung FORTE
10
PR
PR
k.A.
Pulver zur Herstellung einer Lösung zum Einnehmen: 3 Active Agents
Haleon Schweiz AG
B
FB
G
IP
CI
Roclanda
2.5 ml
PR
PR
k.A.
collyre en solution: 2 Active Agents
Santen SA
B
FB
G
IP
CI
Roclanda
3 x 2.5 ml
PR
PR
k.A.
collyre en solution: 2 Active Agents
Santen SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home